Stay updated on T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Sign up to get notified when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.

Latest updates to the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study record history.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.5.0 replaces v3.4.3 in the Record History page.SummaryDifference0.1%

- Check37 days agoChange DetectedA new revision (v3.4.3) was added to the Record History, and the previous revision (v3.4.2) was removed.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and an older maintenance notice (v3.4.1) was removed; the changes pertain to site version updates and operating status notices. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check73 days agoChange DetectedAdded a site-wide notice regarding government funding and the NIH Clinical Center status, and updated the release to Revision: v3.4.1 while removing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check80 days agoChange DetectedThe page adds a 'Show glossary' option and updates the descriptions of color-coded highlights. Revision notes are updated to v3.4.0 and the No FEAR Act data wording is adjusted.SummaryDifference0.9%

Stay in the know with updates to T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.